|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.991
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.988
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.987
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.978
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.813
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.788
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.715
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.713
|
Human |
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.707
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.707
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.701
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.683
|
Human |
|
|
connective tissue development
|
GO:0061448 |
179 |
0.674
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.667
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.646
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.643
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.594
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.582
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.562
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.555
|
Human |
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.516
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.500
|
|
|
|
limb bud formation
|
GO:0060174 |
10 |
0.495
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.490
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.480
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.475
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.462
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.455
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.445
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.421
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.400
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.378
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.376
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.353
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.330
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.319
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.303
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.290
|
Human |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.273
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.270
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.259
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.251
|
Human |
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.239
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.232
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.228
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.226
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.225
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.224
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.223
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.220
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.216
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.215
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.212
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.211
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.206
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.204
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.202
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.202
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.200
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.196
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.194
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.191
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.185
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.170
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.169
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.166
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.165
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.157
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.155
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.153
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.153
|
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.150
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.149
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.148
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.147
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.145
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.144
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.143
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.136
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
14 |
0.134
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.132
|
|
|
|
face development
|
GO:0060324 |
38 |
0.131
|
|
|
|
negative regulation of neuron migration
|
GO:2001223 |
6 |
0.130
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.129
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.129
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.127
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.126
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.124
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.120
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.119
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.118
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.117
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.116
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.114
|
|
|
|
direct ossification
|
GO:0036072 |
5 |
0.111
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.110
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.110
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.108
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.105
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.102
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.102
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.101
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.099
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.096
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.093
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.092
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.090
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.090
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.089
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.088
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.088
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.084
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.084
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.083
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.081
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.081
|
Human |
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.081
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.081
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.079
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.078
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.076
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.075
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.075
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.073
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.072
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.072
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.070
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.067
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.067
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.066
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.066
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.064
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.062
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.061
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.060
|
Human |
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.060
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.058
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.058
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.057
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.057
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.056
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.056
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.056
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.056
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.055
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.054
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.053
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.052
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.051
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.049
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.048
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.048
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.047
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.046
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.045
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.044
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.044
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.044
|
|
|
|
tendon development
|
GO:0035989 |
6 |
0.043
|
|
|
|
otic vesicle development
|
GO:0071599 |
14 |
0.043
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.043
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.043
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.042
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.042
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.042
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.042
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.041
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.041
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.040
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.040
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.039
|
|
|
|
insulin metabolic process
|
GO:1901142 |
3 |
0.039
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.039
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.039
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.038
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.038
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.037
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.036
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.036
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.036
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.035
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.035
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.035
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.035
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.034
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.033
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.033
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.032
|
|
|
|
peptide cross linking via chondroitin 4 sulfate glycosaminoglycan
|
GO:0019800 |
8 |
0.032
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.031
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.031
|
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.031
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.030
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.030
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.029
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.029
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.029
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.028
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.028
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.028
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.027
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.027
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.027
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.027
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.027
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.027
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.027
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.027
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.026
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.026
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.026
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.025
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
7 |
0.025
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.025
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.025
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.025
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.024
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.024
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.023
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.023
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.022
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.022
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.022
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.022
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.022
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.022
|
|
|
|
notochord cell differentiation
|
GO:0060034 |
1 |
0.021
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.021
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.021
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.021
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.021
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.020
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.020
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.020
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.020
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.020
|
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.019
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.019
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.019
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.019
|
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.019
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.018
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.018
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.018
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.017
|
|
|
|
vegf activated neuropilin signaling pathway involved in axon guidance
|
GO:1902378 |
1 |
0.017
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.017
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.017
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.017
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.017
|
|
|
|
response to monoamine
|
GO:0071867 |
4 |
0.017
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.017
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.017
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.017
|
|
|
|
regulation of macrophage migration inhibitory factor signaling pathway
|
GO:2000446 |
1 |
0.016
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.016
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.016
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.016
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.016
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.016
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.016
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.016
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.016
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.015
|
|
|
|
regulation of macrophage chemotaxis
|
GO:0010758 |
8 |
0.015
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.015
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.015
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.015
|
|
|
|
regulation of synaptic vesicle priming
|
GO:0010807 |
4 |
0.015
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.015
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.015
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.014
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.014
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.014
|
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.014
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.014
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.014
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.014
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.014
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.013
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.013
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.013
|
|
|
|
negative regulation of endodermal cell differentiation
|
GO:1903225 |
1 |
0.013
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.013
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.012
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.012
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.012
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.012
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.012
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.012
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
16 |
0.012
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.012
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.012
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.012
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.012
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.012
|
Human |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.012
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.012
|
|
|
|
metanephric glomerular basement membrane development
|
GO:0072274 |
1 |
0.012
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.012
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.011
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.011
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.011
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.011
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.011
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.011
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.011
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.011
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.011
|
|
|
|
macrophage colony stimulating factor signaling pathway
|
GO:0038145 |
2 |
0.011
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.011
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.011
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.011
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.011
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.011
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.011
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.011
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.011
|
|
|
|
medulla oblongata development
|
GO:0021550 |
3 |
0.011
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.011
|
|
|
|
wound healing spreading of cells
|
GO:0044319 |
8 |
0.011
|
|
|
|
renal system vasculature development
|
GO:0061437 |
15 |
0.011
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.011
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.010
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.010
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.010
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.010
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.010
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.010
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.010
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.010
|
|
|
|
macrophage migration inhibitory factor signaling pathway
|
GO:0035691 |
2 |
0.010
|
|
|
|
response to erythropoietin
|
GO:0036017 |
1 |
0.010
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.010
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.010
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.010
|
Human |